Aspen Aerogels (NYSE: ASPN) reported Q4 EPS of $0.14, $0.06 better than the analyst estimate of $0.08. Revenue for the quarter came in at $123.1 million versus the consensus estimate of $114.42 million.

GUIDANCE:

Aspen Aerogels sees Q1 2025 EPS of ($0.18), versus the consensus of $0.08. Aspen Aerogels sees Q1 2025 revenue of $75-95 million, versus the consensus of $104.2 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.